Balloon valvuloplasty in the neonate with critical pulmonary stenosis  by Rao, P. Syamasundar
JACC Vol. 27, No. 2 
February 1996:47Y-I10 
Balloon Valvuloplasty in the 
Neonate W ith Critical 
Pulmonary Stenosis* 
P. SYAMASUNDAR RAO, MD, FACC 
Saint Louis, Missouri 
In this issue of the Journal, Tabatabaei et al. (1) present the 
results of balloon dilation in 37 consecutb.e neonates with 
critical pulmonary stenosis. Reduction in peak to peak systolic 
pressure gradient across the pulmonary valve, decrease in right 
veut;;cular/aortic peak systolic pressure ratio and increase in 
systemic arterial oxygen saturation occurred immediately after 
balloon valvuloplasty. However, the procedure could not be 
accomplished in 2 (6%) of 37 patients; 3 (8%) died after 
valvuloplasty; and 2 (6%) required immediate surgical inter- 
vention. The immediate results are generally similar to those 
reported by other investigators (2-5). In addition, Tabatabaei 
et al. showed improvement in the pulmonary valve leaflet 
mobility and thickness, reductron in the preva!ence of right 
ventricular hypoplasia and increase in pulmonary valve annu- 
lus diameter Z scores at a mean follow-up of 31 months. 
Residual peak instantaneous Doppler gradients remained low 
(15 ? 9 m m  Hg) at the last follow-up visit, and only hvo 
patients (6%) required reintewention. Originally described by 
Tynan et al. (6), balloon pulmonary valvuloplasty has been 
used by several groups (2-57-10) for relief of critical pulmo- 
nary stenosis in the neonate. The germane features of the 
present report (1) are that it includes the largest number of 
neonates that have thus far been evaluated at a sing’e institu- 
tion, and more importantly, it documents improvement and 
maturation of the morphology of the right ventricle and 
pulmonary valve after balloon dilation of critical pulmonary 
stenosis in neonates. They further demonstrated, in a relatively 
large series of neonates, that pulmonary valve dysplasia and 
right ventricular hypoplasia did not have a significant adverse 
effect on either immediate or midterm follow-up results, in 
contradistinction to previous clinical impressions based on a 
small number of patients or, anecdotal experiences (9-11). 
These data, together with those of others (2-lo), reaffirm that 
balloon valvuloplasty is the treatment of choice in the man- 
agement of the neonate with critical pulmonary stenosis. Now 
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that balloon therapy is the treatment of choice, the pediatric 
cardiologist needs to know how best to do it (technique) and 
what problems are likely to be encountered uring the imme- 
diate postvalvuloplasty period. These issues, by design. are not 
discussed in the report of Tabatabaie et al., and I wish to 
address these issues. 
Tecboique of vaIvuIo@sly. The technique of balloon val- 
vuloplasty in neonates is generally similar to that used in older 
children (ll), but the procedure is slightly more dilIicuh to 
accomplish in neonates than in children. The first problem is 
crossing the pulmonary valve. Use of right coronary artery 
catheters (2.5-cm curve) (Cook) or 4F multi-A2 catheters 
(Cordis) in conjunction with soft-tipped guide wires (Bentson. 
Terumo; 0.014 to 0.018-in. supertloppy or high torque and, 
more recently, nirtinol guide wires) made it easier to traverse 
even the most severely stenotic pulmonary valve orifices. The 
second problem is positioning an appropriately sixed balloon 
dilation catheter across the pulmonary valve. If a large-bore 
catheter can be advanced over the guide wire already placed 
across the stenotic valve (as previously discussed), the guide 
wire can be exchanged with a 0.035~in. Teflon-coated stiff 
(extrastiff Amplatz or Medi-Tech) wire. Over this stiff wire, a 
balloon dilation catheter is positioned across the pulmonary 
valve and the balloon inflated. Positioning the stiff wire into the 
descending aorta through the ductus arteriosus, thus anchoring 
the wire steadily makes it easier to appropriately position a 
balloon dilation catheter. If a large-bore catheter cannot be 
passed across the pulmonary valve, it is unlikely that a balloon 
dilation catheter can be positioned across the pulmonary valve. 
In such cases, predilation with a 3- or 4-mm balloon dilation 
catheter (usually a coronary angioplasty catheter*), followed 
by insertion of large-bore catheter, stiff guide wire and appro- 
priately sired balloar catheter successively would accomplii 
balloon pulmonary valvuloplasty (2,3,5,7,11,14). The neonates 
are usually maintained on an intravenous infusion of prostag- 
landin E, and are ventilated during the procedure. It is 
generally agreed that the diameter of the final balloon used for 
dilation should be 1.2 to 1.4 times the size of the pulmonary 
valve annulus (4,!5) and that the baIloon/annuhrs ratio should 
not exceed 1.5 (15). 
Immediate postvakdoplasty folknv-up. After successful 
baitoon pulmonary valvuloplasty, extubation and discontinua- 
tion of prostandii infusion are possible in the majority of cases. 
Some neonates do not tolerate stopping the prostaglandin 
infusion and develop severe arterial desaturation. As many as 
17% to 27% of patients may require prostaglandin infusion for 
3 to 21 days after balloon vahuloplasty (1,4,5,16). Right to left 
shunting across the patent foremen ovale, presumably related 
to a ,poorly compliant right ventricle, ;is the cause of arterial 
desaturation. Some of these infants may require either pro- 
longed infusion of prostaglandins or creation of an aortopul- 
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monary shunt to augment pulmonary blood flow. An alterua- 
tive consideration is placement of stents (17) in the patent 
ductus arteriosus, although the experience with ductal stems is 
limited, and ductal stents are considered experimental. 
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Conclusions. Balloon pulmonary valvuloplasty appears 
feasible, effective and relatively safe in the initial management 
of critical pulmonary valve stenosis in the neonate. The 
majority of patients require no additional intervention, and 
appear to have remodeled ventricles and pulmonary valves at 
follow-up. Approximately 25% of patients may require surgical 
or repeat ranscatheter intervention to treat unsuccessful di a- 
tion attempts, manage complications of the procedure, aug- 
ment pulmonary flow despite “successful” balloon valvulo- 
plasty or relieve recurrent pulmonary valve obstruction. 
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